Cite
MLA Citation
Anthony Marson et al.. “The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.” Lancet, vol. 397, no. 10282, 2021, pp. 1363–1374. http://access.bl.uk/ark:/81055/vdc_100159421243.0x000039